RSS

erectile dysfunction (ED)

Following the publication of Phase II trial data, Futura Medical announces encouraging results, significant improvements in erectile function scores and a favourable safety profile with its topical drug, MED2005. more

Technology

CURE Pharmaceutical, a disruptive drug delivery technology and pharmaceutical cannabinoid molecule company, has formed a partnership with a pharmaceutical distribution company to deliver a generic ED drug into the Asian market. more

News

Two brothers have been sentenced at Chelmsford Crown Court for the illegal importation and sale of unlicensed erectile dysfunction drugs more

News

Nearly £1 million worth of unlicensed erectile dysfunction medicines were seized by enforcement officers from the Medicines and Healthcare products Regulatory Agency (MHRA) more

News

A UK man is sentenced to 16 months’ imprisonment for the illegal sale of erectile dysfunction drugs following an investigation by MHRA more

News

Futura Medical has received all regulatory approvals needed for the efficacy trial of MED2002, its topical gel for the treatment of erectile dysfunction, and pre-screening of patients has begun. more

News